Who owns ENTERO THERAPEUTICS INC?
- Ticker: GRDX
- CUSIP Number: 33749p507
Tip: Access positions for across all investors
Analyze quarterly positions in Entero Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Entero Therapeutics stock
Who bought or sold ENTERO THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| DRW Holdings | 49k | $227k | 100% | Dec 2025 |
|
| Renaissance Technologies | 31k | $145k | -64% | Dec 2025 |
|
| FNY Investment Advisers | 28k | $128k | 100% | Dec 2025 |
|
| State Street Corporation | 23k | $109k | 21% | Dec 2025 |
|
| Vanguard Group | 22k | $101k | 0% | Dec 2025 |
|
| Geode Capital Management | 20k | $95k | 60% | Dec 2025 |
|
| SBI Securities | 553.00 | $2.8k | 100% | Sep 2025 |
|
| UBS Group | 536.00 | $2.5k | 712% | Dec 2025 |
|
| Advisor Group Holdings | 1.00 | $4.000000 | 100% | Dec 2025 |
|
| Danske Bank A/s | 1.00 | $5.000000 | 0% | Dec 2025 |
|
Who sold out of Entero Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Virtu Financial | Sep 2025 | 12k | $59k |